Difference between revisions of "Venlafaxine-tranylcypromine"
From Psychiatrienet
| Line 10: | Line 10: | ||
* '''Day 15:''' start administration of tranylcypromine in a low dosage of 20 mg/day for one week. | * '''Day 15:''' start administration of tranylcypromine in a low dosage of 20 mg/day for one week. | ||
* '''Day 22:''' after this week the dosage of tranylcypromine can be increased if necessary. | * '''Day 22:''' after this week the dosage of tranylcypromine can be increased if necessary. | ||
| − | | | + | | caveat = |
| − | |||
* Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.}} | * Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.}} | ||
Revision as of 16:24, 17 July 2009
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from venlafaxine to tranylcypromine.[1] [2]
Stop venlafaxine - Day 0: gradually reduce dosage of venlafaxine to a maximum of 75 mg/ day.
- Day 1: reduce a dosage of 75 mg/day to 37,5 mg/day.
- Day 8: stop administration of venlafaxine.
Start tranylcypromine- Day 8-14: a wash-out period one week is necessary.
- Day 15: start administration of tranylcypromine in a low dosage of 20 mg/day for one week.
- Day 22: after this week the dosage of tranylcypromine can be increased if necessary.
Cave- Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
